Eli Lilly's lead in the obesity race has grown. Its recent stock performance says otherwise

Eli Lilly has been one of the worst-performing Club stocks over the past six months.

...

These 3 stocks are troubled but I'm not ready to give up

3 weeks ago

Pfizer, Moderna and Novavax gear up for fall Covid vaccine rollout with an important head start

3 weeks ago

NY Gov. Hochul signs bill to protect abortion providers sending pills into states with bans

3 weeks ago

How New York City's sky-high cost of living stacks up to London

3 weeks ago

Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says

2 weeks ago